Wird geladen...
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: 2-Year Results: Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group
OBJECTIVE: To describe effects of ranibizumab and bevacizumab when administered monthly or as needed for two years and to describe the impact of switching to as-needed treatment after a year of monthly treatment. DESIGN: Multicenter, randomized clinical trial. PARTICIPANTS: Patients (N=1107) who wer...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3389193/ https://ncbi.nlm.nih.gov/pubmed/22555112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.03.053 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|